Epidemiology and Demographics of Upper Gastrointestinal Bleeding: Prevalence, Incidence, and Mortality

Gastrointestinal Endoscopy Clinics of North America

Volumn 21, Issue 4, 2011, Pages 567-581

  Sostres, Carlos ^a   Lanas, Angel ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Epidemiology; Mortality; Time trends; Upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTICOAGULANT AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; ROFECOXIB;

ANTICOAGULATION; CLINICAL PRACTICE; COMORBIDITY; DEMOGRAPHY; DIGESTIVE SYSTEM PERFORATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; DUODENUM ULCER; ERADICATION THERAPY; GASTRODUODENAL ULCER; HELICOBACTER INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LOW DRUG DOSE; MORTALITY; PATIENT CARE; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH ULCER; ULCER HEALING; UPPER GASTROINTESTINAL BLEEDING;

GASTROINTESTINAL HEMORRHAGE; HUMANS; INCIDENCE; PREVALENCE; RECURRENCE; RISK FACTORS; UPPER GASTROINTESTINAL TRACT;

EID: 80053178022     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2011.07.004     Document Type: Review

References (100)

1. Vreeburg E.M., Snel P., de Bruijne J.W., et al. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997, 92(2):236-243.
2. Longstreth G.F. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995, 90(2):206-210.
3. Czernichow P., Hochain P., Nousbaum J.B., et al. Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol 2000, 12(2):175-181.
4. Thomopoulos K.C., Vagenas K.A., Vagianos C.E., et al. Changes in aetiology and clinical outcome of acute upper gastrointestinal bleeding during the last 15 years. Eur J Gastroenterol Hepatol 2004, 16(2):177-182.
5. Blatchford O., Davidson L.A., Murray W.R., et al. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997, 315(7107):510-514.
6. Rockall T.A., Logan R.F., Devlin H.B., et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995, 311:222-226.
7. Paspatis G.A., Matrella E., Kapsoritakis A., et al. An epidemiological study of acute upper gastrointestinal bleeding in Crete, Greece. Eur J Gastroenterol Hepatol 2000, 12(11):1215-1220.
8. Boonpangmanee S., Fleischer D.E., Pezzullo J.C., et al. The frequency of peptic ulcer as a cause of upper GI bleedings exaggerated. Gastrointest Endosc 2004, 59:788-794.
9. Langman M.J., Jensen D.M., Watson D.J., et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999, 282:1929-1933.
10. Emery P., Zeider H., Kvein T.K., et al. Celecoxib versus diclofenac in long term management of rheumatoid arthritis; randomised double blind comparison. Lancet 1999, 354:2106-2111.
11. Hunt R.H., Harpers S., Watson D.J., et al. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed both by endoscopy and analysis of upper gastrointestinal events. Am J Gastroenterol 2003, 98:1725-1733.
12. Goldstein J.L., Esien G.M., Agrawal N., et al. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor valdecoxib. Aliment Pharmacol Ther 2004, 20:527-538.
13. del Olmo J.A., Pena A., Serra M.A., et al. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000, 32(1):19-24.
14. Afessa B., Kubilis P.S. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol 2000, 95(2):484-489.
15. Lecleire S., Di Fiore F., Merle V., et al. Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol 2005, 39(4):321-327.
16. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000, 33(5):846-852.
17. Wilcox C.M., Alexander L.N., Straub R.F., et al. A prospective endoscopic evaluation of the causes of upper GI hemorrhage in alcoholics: a focus on alcoholic gastropathy. Am J Gastroenterol 1996, 91:1343-1347.
18. Llach J., Elizalde J.I., Guevara M.C., et al. Endoscopic injection therapy in bleeding Mallory-Weiss syndrome: a randomized controlled trial. Gastrointest Endosc 2001, 54(6):679-681.
19. Huang S.P., Wang H.P., Lee Y.C., et al. Endoscopic hemoclip placement and epinephrine injection for Mallory-Weiss syndrome with active bleeding. Gastrointest Endosc 2002, 55(7):842-846.
20. Cheng C.L., Lee C.S., Liu N.J., et al. Overlooked lesions at emergency endoscopy for acute nonvariceal upper gastrointestinal bleeding. Endoscopy 2002, 34(7):527-530.
21. Romãozinho J.M., Pontes J.M., Lérias C., et al. Dieulafoy's lesion: management and long-term outcome. Endoscopy 2004, 36(5):416.
22. Park C.H., Joo Y.E., Kim H.S., et al. A prospective, randomized trial of endoscopic band ligation versus endoscopic hemoclip placement for bleeding gastric Dieulafoy's lesions. Endoscopy 2004, 36(8):677-681.
23. Savides T.J., Jensen D.M., Cohen J., et al. Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome. Endoscopy 1996, 28(2):244-248.
24. Ramsoekh D., van Leerdam M.E., Rauws E.A., et al. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection. Clin Gastroenterol Hepatol 2005, 3(9):859-864.
25. Laine L. Approaches to NSAID use in the high-risk patient. Gastroenterology 2001, 120:594-606.
26. Laine L., Harper S., Simon T., et al. A randomized trial comparing the effect of rofecoxib, a COX-2 specific inhibitor, to ibuprofen on the gastroduodenal mucosa of osteoarthritis patients. Gastroenterology 1999, 117:776-783.
27. Lanas A., Fuentes J., Benito R., et al. Helicobacter pylori increases the risk of gastrointestinal bleeding in patients taking low dose aspirin. Gastroenterology 2000, 118:A252.
28. Fries J.F., Murtagh K.N., Bennett M., et al. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis. Arthritis Rheum 2004, 50(8):2433-2440.
29. Laine L., Bombardier C., Hawkey C.J., et al. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 2002, 123(4):1006-1012.
30. Langman M.J., Weil J., Wainwright P., et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994, 343:1075-1078.
31. Stack W.A., Hawkey G.M., Atherton J.C., et al. Interaction of risk factors for peptic ulcer bleeding. Gastroenterology 1999, 116:A97.
32. Sorensen H.T., Mellemkjaer L., Blot W.J., et al. Risk of upper gastrointestinal bleeding associated with use of low dose aspirin. Am J Gastroenterol 2000, 95:2218-2224.
33. Lanas A., Bajador E., Serrano P., et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 2000, 343:834-839.
34. Weil J., Colin-Jones D., Langman M., et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995, 310:827-830.
35. Goggin P.M., Collins D.A., Jazrawi R.P., et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut 1993, 34:1677-1680.
36. Kim J.G., Graham D.Y. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 1994, 89:203-207.
37. Thillainayagam A.V., Tabaqchali S., Warrington S.J., et al. Interrelationships between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, and gastroduodenal disease: a prospective study in healthy volunteers. Dig Dis Sci 1994, 39:1085-1089.
38. Laine L., Cominelli F., Sloane R., et al. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind study. Aliment Pharmacol Ther 1995, 9:127-135.
39. Huang J.Q., Sridhar S., Hunt R.H. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002, 359(9300):14-22.
40. Vergara M., Catalan M., Gisbert J.P., et al. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005, 21:1411-1418.
41. Venerito M., Malfertheiner P. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers. Helicobacter 2010, 15(4):239-250.
42. Bombardier C., Laine L., Reicin A., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000, 343:1520-1528.
43. Schnitzer T.J., Burmester G.R., Mysler E., et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 2004, 364:665-674.
44. Garcia Rodriguez L.A., Barreales T.L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 2007, 132(2):498-506.
45. Lanas A., Baron J.A., Sandler R.S., et al. Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology 2007, 132(2):490-497.
46. Elashoff J.D., Grossman M.I. Trends in hospital admissions and death rates for peptic ulcer in the United States from 1970 to 1978. Gastroenterology 1980, 78(2):280-285.
47. Brown R.C., Langman M.J. Proceedings: hospital admission for peptic ulcer and acute gastrointestinal bleeding in the United Kingdom 1958-70. Gut 1974, 15(4):335.
48. Primatesta P., Goldacre M.J., Seagroatt V. Changing patterns in the epidemiology and hospital care of peptic ulcer. Int J Epidemiol 1994, 23(6):1206-1217.
49. Jibril J.A., Redpath A., Macintyre I.M. Changing pattern of admission and operation for duodenal ulcer in Scotland. Br J Surg 1994, 81(1):87-89.
50. Lewis J.D., Bilker W.B., Brensinger C., et al. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol 2002, 97(10):2540-2549.
51. Bardhan K.D., Cust G., Hinchliffe R.F., et al. Changing pattern of admissions and operations for duodenal ulcer. Br J Surg 1989, 76(3):230-236.
52. Thors H., Svanes C., Thjodleifsson B. Trends in peptic ulcer morbidity and mortality in Iceland. J Clin Epidemiol 2002, 55(7):681-686.
53. Sonnenberg A. Time trends of ulcer mortality in Europe. Gastroenterology 2007, 132(7):2320-2327.
54. Sonnenberg A. Time trends of ulcer mortality in non-European countries. Am J Gastroenterol 2007, 102(5):1101-1107.
55. van Leerdam M.E., Vreeburg E.M., Rauws E.A., et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003, 98(7):1494-1499.
56. Yavorski R.T., Wong R.K., Maydonovitch C., et al. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 1995, 90(4):568-573.
57. Lanas A., Tafalla M., Nuevo J. Clinical predictors of bleeding continuation or re-bleeding after an initial episode of non variceal upper gastrointestinal bleeding: an observational European study. Am J Gastroenterol 2009, 104:S40-S60.
58. Sung J.J., Kuipers E.J., El-serag H.B. Systematic review. The global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009, 29:938-946.
59. Post P.N., Kuipers E.J., Meijer G.A. Declining incidence of peptic ulcer but not of its complications: a nation-wide study in The Netherlands. Aliment Pharmacol Ther 2006, 23:1587-1593.
60. Ohmann C., Imhof M., Ruppert C., et al. Time-trends in the epidemiology of peptic ulcer bleeding. Scand J Gastroenterol 2005, 40:914-920.
61. Kang J.Y., Elders A., Majeed A., et al. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006, 24:65-79.
62. Paimela H., Paimela L., Myllykangas-Luosujarvi R., et al. Current features of peptic ulcer disease in Finland: incidence of surgery, hospital admissions and mortality for the disease during the past twenty-five years. Scand J Gastroenterol 2002, 37:399-403.
63. Sadic J., Borgström A., Manjer J., et al. Bleeding peptic ulcer-time trends in incidence, treatment and mortality in Sweden. Aliment Pharmacol Ther 2009, 30(4):392-398. Epub 2009 Jun 6.
64. Lanas A., García-Rodríguez L.A., Polo-Tomás M., et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009, 104(7):1633-1641.
65. Zhao Y., Encinosa W. Hospitalizations for gastrointestinal bleeding in 1998 and 2006 2008, HCUP statistical brief #65, Agency for Healthcare Research and Quality, Rockville (MD), Available at:, Accessed July 11, 2011. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb65.pdf.
66. Lanas A., García-Rodríguez L.A., Polo-Tomás M., et al. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Ther 2011, 33(5):585-591.
67. Pérez-Aisa M.A., Del Pino D., Siles M., et al. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 2005, 21(1):65-72.
68. Laine L., Peterson W. Medical progress: bleeding peptic ulcer. N Engl J Med 1994, 331:717-727.
69. Kubba A.K., Murphy W., Palmer K.R. Endoscopic injection for bleeding peptic ulcer: a comparison of adrenaline alone with adrenaline plus human thrombin. Gastroenterology 1996, 111(3):623-628.
70. Rockall T.A., Logan R.F.A., Devlin H.B., et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996, 38:316-321.
71. Barkun A., Bardou M., Marshall J. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003, 139:843-857.
72. Jensen D.M., Kovacs T.O., Jutabha R., et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002, 123:407-413.
73. Kollef M.H., O'Brien J.D., Zuckerman G.R., et al. A classification tool to predict outcomes in patients with acute upper and lower gastrointestinal hemorrhage. Crit Care Med 1997, 25:1125-1132.
74. Wong S.K., Yu L.M., Lau J.Y., et al. Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut 2002, 50:322-325.
75. Andriulli A., Annese V., Caruso N., et al. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcer: a series of meta-analyses. Am J Gastroenterol 2005, 100:207-219.
76. Udd M., Miettinen P., Palmu A., et al. Regular-dose versus high dose omeprazole in peptic ulcer bleeding. Scand J Gastroenterol 2001, 36:1332-1338.
77. Lin H.J., Lo W.C., Cheng Y.C., et al. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial. Am J Gastroenterol 2006, 101:500-505.
78. Coskun F., Topeli A., Sivri B. Patients admitted to the emergency room with upper gastrointestinal bleeding: factors influence recurrence or death. Adv Ther 2005, 22:453-461.
79. Thomopoulos K.C., Theocharis G.J., Vagenas K.A., et al. Predictors of hemostatic failure after adrenaline injection in patients with non-bleeding visible vessel. Scand J Gastroenterol 2004, 39:600-604.
80. Cheng H.C., Chuang S.A., Kao Y.H., et al. Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastroenterology 2003, 50:2270-2273.
81. Chung I.K., Kim E.J., Lee M.S., et al. Endoscopic factors predisposing to rebleeding following endoscopic hemostasis in bleeding peptic ulcers. Endoscopy 2001, 33:969-975.
82. Thomopoulos K.C., Mitropoulos J.A., Katsakoulis E.C., et al. Factors associated with failure of endoscopic injection hemostasis in bleeding peptic ulcers. Scand J Gastroenterol 2001, 36:664-668.
83. Hasselgren G., Carlsson J., Lind T., et al. Risk factors for rebleeding and fatal outcome in elderly patients with acute peptic ulcer bleeding. Eur J Gastroenterol Hepatol 1998, 10:667-672.
84. Lin H.J., Tseng G.Y., Lo W.C., et al. Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation: a retrospective analysis. J Clin Gastroenterol 1998, 26:113-116.
85. Brullet E., Campo R., Calvet X., et al. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. Gut 1996, 39:155-158.
86. Fischer I., Madsen M.R., Thomsen H., et al. Peptic ulcer hemorrhage: factors predisposing to recurrence. Scand J Gastroenterol 1994, 29:414-418.
87. Franicki F.J., Coleman S.Y., Fok P.J., et al. Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg 1990, 14:262-269.
88. Wolf A.T., Wasan S.K., Saltzman J.R. Impact of anticoagulation on rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage. Am J Gastroenterol 2007, 102(2):290-296.
89. Travis A.C., Wasan S.K., Saltzman J.R. Model to predict rebleeding following endoscopic therapy for non-variceal upper gastrointestinal hemorrhage. J Gastroenterol Hepatol 2008, 23(10):1505-1510.
90. Tramèr M.R., Moore R.A., Reynolds D.J., et al. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain 2000, 85:169-182.
91. Lim C.H., Vani D., Shah S.G., et al. The outcome of suspected upper gastrointestinal bleeding with 24-hour access to upper gastrointestinal endoscopy: a prospective cohort study. Endoscopy 2006, 38:581-585.
92. Rostom A., Muir K., Dubé C., et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol 2007, 5:818-828.
93. Bown T.J., Hooper L., Elliott R.A., et al. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. Health Technol Assess 2006, 10:iii-iiv. xi-xiii, 1-183.
94. Lanas A. Editorial: upper GI bleeding-associated mortality: challenges to improving a resistant outcome. Am J Gastroenterol 2010, 105(1):90-92.
95. Christensen S., Riis A., Norgaard M., et al. Short-term mortality after perforated or bleeding peptic ulcer among elderly patients: a population-based cohort study. BMC Geriatr 2007, 7:8.
96. Zimmerman J., Siguencia J., Tsvang E., et al. Predictors of mortality in patients admitted to hospital for acute upper gastrointestinal hemorrhage. Scand J Gastroenterol 1995, 30:327-331.
97. Lanza F.L. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998, 93:2037-2046.
98. Higham J., Kang J.Y., Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut 2002, 50:460-464.
99. Laszlo A., Kelly J.P., Kaufman D.E., et al. Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal antiinflammatory drugs. Am J Gastroenterol 1998, 93:721-725.
100. Theocharis G.J., Arvaniti V., Assimakopoulos S.F., et al. Acute upper gastrointestinal bleeding in octogenarians: clinical outcome and factors related to mortality. World J Gastroenterol 2008, 14(25):4047-4053.